Search results for the GEO ID: GSE41035
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM1007032
GPL570
control-plusDox-rep1 bladder cancer cells treated 48 hr cell line: RT112 transduced: EGFP shRNA doxycycline treatment: yes
GSM1007033
GPL570
control-plusDox-rep3 bladder cancer cells treated 48 hr cell line: RT112 transduced: EGFP shRNA doxycycline treatment: yes
GSM1007034
GPL570
shRNA2-4-noDox-rep2 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 2-4 doxycycline treatment: no
GSM1007035
GPL570
shRNA2-4-plusDox-rep1 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 2-4 doxycycline treatment: yes
GSM1007036
GPL570
shRNA2-4-plusDox-rep3 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 2-4 doxycycline treatment: yes
GSM1007037
GPL570
shRNA4-1-noDox-rep2 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 4-1 doxycycline treatment: no
GSM1007038
GPL570
shRNA4-1-plusDox-rep1 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 4-1 doxycycline treatment: yes
GSM1007039
GPL570
shRNA4-1-plusDox-rep3 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 4-1 doxycycline treatment: yes
GSM1007040
GPL570
shRNA6-16-noDox-rep2 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 6-16 doxycycline treatment: no
GSM1007041
GPL570
shRNA6-16-plusDox-rep1 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 6-16 doxycycline treatment: yes
GSM1007042
GPL570
shRNA6-16-plusDox-rep3 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 6-16 doxycycline treatment: yes
GSM1007043
GPL570
control-noDox-rep1 bladder cancer cells treated 48 hr cell line: RT112 transduced: EGFP shRNA doxycycline treatment: no
GSM1007044
GPL570
control-noDox-rep2 bladder cancer cells treated 48 hr cell line: RT112 transduced: EGFP shRNA doxycycline treatment: no
GSM1007045
GPL570
control-noDox-rep3 bladder cancer cells treated 48 hr cell line: RT112 transduced: EGFP shRNA doxycycline treatment: no
GSM1007046
GPL570
control-plusDox-rep2 bladder cancer cells treated 48 hr cell line: RT112 transduced: EGFP shRNA doxycycline treatment: yes
GSM1007047
GPL570
shRNA2-4-noDox-rep1 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 2-4 doxycycline treatment: no
GSM1007048
GPL570
shRNA2-4-noDox-rep3 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 2-4 doxycycline treatment: no
GSM1007049
GPL570
shRNA2-4-plusDox-rep2 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 2-4 doxycycline treatment: yes
GSM1007050
GPL570
shRNA4-1-noDox-rep1 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 4-1 doxycycline treatment: no
GSM1007051
GPL570
shRNA4-1-noDox-rep3 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 4-1 doxycycline treatment: no
GSM1007052
GPL570
shRNA4-1-plusDox-rep2 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 4-1 doxycycline treatment: yes
GSM1007053
GPL570
shRNA6-16-noDox-rep1 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 6-16 doxycycline treatment: no
GSM1007054
GPL570
shRNA6-16-noDox-rep3 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 6-16 doxycycline treatment: no
GSM1007055
GPL570
shRNA6-16-plusDox-rep2 bladder cancer cells treated 48 hr cell line: RT112 transduced: FGFR3 shRNA 6-16 doxycycline treatment: yes
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes